Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Ageing Res Rev. 2020 Feb 25;59:101037. doi: 10.1016/j.arr.2020.101037

Table 3.

Number of clinical trials available by drug and age or age-related condition. On ClinicalTrials.gov, “condition/disease” is defined as “the disease, disorder, syndrome, illness, or injury that is being studied”. We found ∼12,100 clinical trials that target age or age-related diseases with 510 clinical trials aimed toward “Aging as a condition or disease”. Of note, we have added anti-aging interventions such as CR, exercise, fasting, and ketogenic diet, although they are not the focus of the review. To date, exercise is the “anti-aging” intervention with the most on-going clinical trials.

DRUGS AGING* AD** AMD CANCER CDV FRAILTY MET.S** OSTEOA OSTEOP PD SARCOPENIA T2D***
ACARBOSE 2 0 0 4 19 0 1 0 0 0 0 67
ASPIRIN 1 0 3 161 1008 0 3 2 0 0 0 53
CURCUMIN 9 5 0 65 8 0 7 4 0 0 0 8
GDF8 2 0 0 0 0 0 0 0 0 0 2 0
GREEN TEA 5 0 0 97 31 0 2 1 1 1 0 17
METFORMIN 11 3 1 335 105 4 62 0 0 0 1 1337
METHYLENE BLUE 1 7 0 43 2 0 0 0 0 0 0 0
NAD_NAD precursors 12 2 0 13 57 1 9 0 0 0 2 9
POLYAMINES 1 2 0 5 0 0 0 0 0 0 0 0
QUERCETIN 2 1 0 13 4 0 0 0 0 0 0 2
RAPAMYCIN 11 0 12 1106 473 0 0 0 0 0 1 1
RESVERATROL 10 5 2 15 10 0 13 1 2 6 1 15
SRT2104 0 0 0 0 0 0 0 0 0 0 2 7
SRT3025 0 0 0 0 0 0 0 0 0 0 0 1
SIMVASTATIN 1 8 0 58 172 0 14 0 1 1 0 42
TRYPTOPHAN 0 2 0 3 9 0 0 0 0 1 0 0
INTERVENTIONS
CALORIC RESTRICTION 15 7 0 57 20 0 22 3 0 0 0 31
EXERCISE 435 167 0 1214 1979 80 229 331 93 179 121 628
FASTING 20 21 2 281 240 0 50 15 12 22 4 339
KETOGENIC DIET 0 9 0 26 4 0 2 0 0 2 0 7
TOTAL 538 239 20 3496 4141 85 414 357 109 212 134 2564
*

Includes age, aging and longevity.

**

Includes Alzheimer’s disease, dementia and mild cognitive impairment; AD (Alzheimer’s disease); CDV (cardiovascular disease); Met.S (metabolic syndrome); Osteoa (osteoarthritis); Osteop (osteoporosis); PD (Parkinson’s disease); T2D (type 2 diabetes).